Literature DB >> 2882516

Specific binding of atrial natriuretic factor in brain microvessels.

P E Chabrier, P Roubert, P Braquet.   

Abstract

Cerebral capillaries constitute the blood-brain barrier. Studies of specific receptors (neurotransmitters or hormones) located on this structure can be performed by means of radioligand-binding techniques on isolated brain microvessels. We examined on pure bovine cerebral microvessel preparations the binding of atrial natriuretic factor (ANF), using 125I-labeled ANF. Saturation and competition experiments demonstrated the presence of a single class of ANF-binding sites with high affinity (dissociation constant, approximately 10(-10) M) and with a binding capacity of 58 fmol/mg of protein. The binding of 125I-labeled ANF to brain microvessels is specific, reversible, and time dependent, as is shown by association-dissociation experiments. The demonstration of specific ANF-binding sites on brain microvessels supposes a physiological role of ANF on brain microvasculature. The coexistence of ANF and angiotensin II receptors on this cerebrovascular tissue suggests that the two circulating peptides may act as mutual antagonists in the regulation of brain microcirculation and/or blood-brain barrier function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2882516      PMCID: PMC304588          DOI: 10.1073/pnas.84.7.2078

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Isolation of metabolically active capillaries from rat brain.

Authors:  G W Goldstein; J S Wolinsky; J Csejtey; I Diamond
Journal:  J Neurochem       Date:  1975-11       Impact factor: 5.372

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Angiotensin II receptor binding sites in brain microvessels.

Authors:  R C Speth; S I Harik
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

4.  Leakage of serum proteins in brain tissues in experimentally induced renal hypertension.

Authors:  K Onoyama; T Omae
Journal:  Acta Neurol Scand       Date:  1973       Impact factor: 3.209

5.  A continuous spectrophotometric method for measuring the activity of serum alkaline phosphatase.

Authors:  G N Bowers; R B McComb
Journal:  Clin Chem       Date:  1966-02       Impact factor: 8.327

6.  A routine procedure for estimating serum gamma-glutamyltranspeptidase activity.

Authors:  L Naftalin; M Sexton; J F Whitaker; D Tracey
Journal:  Clin Chim Acta       Date:  1969-11       Impact factor: 3.786

Review 7.  Brain barrier pathology in acute arterial hypertension.

Authors:  B Johansson
Journal:  Adv Exp Med Biol       Date:  1976       Impact factor: 2.622

8.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

9.  Decreased number and affinity of rat atrial natriuretic peptide (6-33) binding sites in the subfornical organ of spontaneously hypertensive rats.

Authors:  J M Saavedra; A Israel; M Kurihara; E Fuchs
Journal:  Circ Res       Date:  1986-03       Impact factor: 17.367

10.  Pharmacology and receptor binding of atrial natriuretic factor in vascular smooth muscle.

Authors:  R J Winquist; M A Napier; R L Vandlen; K Arcuri; M E Keegan; E P Faison; E P Baskin
Journal:  Clin Exp Hypertens A       Date:  1985
View more
  8 in total

1.  Localization of 125I-atrial natriuretic peptide (ANP) in the rat fetus.

Authors:  J N Scott; L Jennes
Journal:  Anat Embryol (Berl)       Date:  1991

2.  Atrial natriuretic peptide is eliminated from the brain by natriuretic peptide receptor-C-mediated brain-to-blood efflux transport at the blood-brain barrier.

Authors:  Shingo Ito; Sumio Ohtsuki; Yuki Katsukura; Miho Funaki; Yusuke Koitabashi; Akihiko Sugino; Sho Murata; Tetsuya Terasaki
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-14       Impact factor: 6.200

3.  Atrial natriuretic peptides elevate cyclic GMP levels in primary cultures of rat ependymal cells.

Authors:  John Wellard; Mirna Rapp; Bernd Hamprecht; Stephan Verleysdonk
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

4.  Macromolecular permeability across the blood-nerve and blood-brain barriers.

Authors:  J F Poduslo; G L Curran; C T Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

Review 5.  Atrial natriuretic peptide in the central nervous system of the rat.

Authors:  G Skofitsch; D M Jacobowitz
Journal:  Cell Mol Neurobiol       Date:  1988-12       Impact factor: 5.046

6.  Atrial natriuretic peptide and angiotensin II binding sites in cerebral capillaries of spontaneously hypertensive rats.

Authors:  M Ibaragi; M Niwa
Journal:  Cell Mol Neurobiol       Date:  1989-06       Impact factor: 5.046

7.  Atrial natriuretic peptide binding in rat placenta, yolk sac, decidua, and maternal placental vessels.

Authors:  J N Scott
Journal:  Cell Tissue Res       Date:  1993-05       Impact factor: 5.249

8.  N-Terminal Pro Brain, N-Terminal Pro Atrial Natriuretic Peptides, and Dynamic Cerebral Autoregulation.

Authors:  Simin Mahinrad; Behnam Sabayan; Chaney R Garner; Donald M Lloyd-Jones; Farzaneh A Sorond
Journal:  J Am Heart Assoc       Date:  2020-10-16       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.